Showing results (351-360 of 391) with videos related to

Sort By:
Pageof 40
The Journal of Clinical Endocrinology and Metabolism|September 2, 2011
GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1Yee-Ming Chan, Sarabeth Broder-Fingert, Sophia Paraschos, et al.
Pediatric Blood & Cancer|August 14, 2020
SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settingsNisreen Amayiri, Ariane Spitaels, Mohamed Zaghloul, et al.
Neuro-Oncology Advances|June 25, 2021
Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patientsElisa Izquierdo, Paula Proszek, Giulia Pericoli, et al.
Nature Communications|August 30, 2020
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunityYura Grabovska, Alan Mackay, Patricia O'Hare, et al.
Acta Neuropathologica|May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesTanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Acta Neuropathologica|April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratificationJack Goddard, Jemma Castle, Emily Southworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitorsKevin K-C Liu, Shubha Bagrodia, Simon Bailey, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Neuro-Oncology|October 14, 2022
A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomesKatherine Green, Paraskevi Panagopoulou, Felice D'Arco, et al.
Neuro-Oncology Advances|June 23, 2022
Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updatesGerrit H Gielen, Joshua N Baugh, Dannis G van Vuurden, et al.
Pageof 40